Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Recurrence and CYP2C9[original query] |
|---|
| Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence. Clinical cancer research : an official journal of the American Association for Cancer Research 2006 Nov 12 (21): 6585-9. Hubner Richard A, Muir Kenneth R, Liu Jo-Fen, Logan Richard F A, Grainge Matthew, Armitage Nicholas, Shepherd Vic, Popat Sanjay, Houlston Richard S, |
| Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast cancer research : BCR 2010 12 (3): R26. Gor Priya P, Su H Irene, Gray Robert J, Gimotty Phyllis A, Horn Michelle, Aplenc Richard, Vaughan William P, Tallman Martin S, Rebbeck Timothy R, DeMichele Ange |
| CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer causes & control : CCC 2012 Oct . Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM |
| Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment 2014 Oct 147 (3): 557-70. Vulsteke C, Pfeil A M, Schwenkglenks M, Pettengell R, Szucs T D, Lambrechts D, Peeters M, van Dam P, Dieudonné A S, Hatse S, Neven P, Paridaens R, Wildiers |
| Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis : JTH 2017 Aug . Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer J H, Osterwalder J, Frauchiger B, Aschwanden M, Matter C M, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky |
| Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain. Scientific reports 2020 Feb 10 (1): 2806. Cullell Natalia, Carrera Caty, Muiño Elena, Torres-Aguila Nuria-Paz, Cárcel-Márquez Jara, González-Sánchez Jonathan, Gallego-Fabrega Cristina, Molina Jessica, Besora Sarah, Sotoca Javier, Buongiorno Maria-Teresa, Jiménez-Conde Jordi, Giralt-Steinhauer Eva, de Torres-Chacón Reyes, Montaner Joan, Mancha Fernando, Cabezas Juan A, Martí-Fàbregas Joan, Prats-Sánchez Luis, Camps-Renom Pol, Purroy Francisco, Cambray Serafi, Freijo María Del Mar, Vives-Bauzá Cristòfol, Tur Silvia, Font Maria-Àngels, López-Cancio Elena, Hernandez-Perez Maria, Obach Victor, Calleja Ana, Arenillas Juan, Rodríguez-Yáñez Manuel, Castillo José, Sobrino Tomas, Fernández-Cádenas Israel, Krupinski Jer |
| Enriching Medication Review with a Pharmacogenetic Profile - A Case of Tamoxifen Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2021 14 279-286. Jeiziner Chiara, Stäuble Céline K, Lampert Markus L, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: